Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil (Q38964634)

8 September 2017

title

Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil (English)

1 reference

8 September 2017

0 references

0 references

4

1 reference

Ana Paula Junqueira-Kipnis

8 September 2017

6

object named as

Ana Paula Junqueira-Kipnis

1 reference

8 September 2017

author name string

João Alves de Araújo-Filho

1

1 reference

8 September 2017

Arioldo Carvalho Vasconcelos

2

1 reference

8 September 2017

Eduardo Martins de Sousa

3

1 reference

8 September 2017

Elisângela Ribeiro

5

1 reference

8 September 2017

publication date

26 July 2008

1 reference

8 September 2017

1 reference

8 September 2017

volume

88

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

474-481

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

8 September 2017

1 reference

The TB pandemic: an old problem seeking new solutions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Immunology of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Immune factors and immunoregulation in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Detection of in vitro interferon-gamma and serum tumour necrosis factor-alpha in multidrug-resistant tuberculosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Role of stress response sigma factor SigG in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Combined Use of Serum and Urinary Antibody for Diagnosis of Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Humoral immune responses of tuberculosis patients in Brazil indicate recognition of Mycobacterium tuberculosis MPT-51 and GlcB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Cost of treatment for multidrug-resistant tuberculosis in South Korea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

The effect of drug resistance on the fitness of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

An update on the diagnosis of tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Abnormal production of transforming growth factor beta and interferon gamma by peripheral blood cells of patients with multidrug-resistant pulmonary tuberculosis in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Models of the within-host dynamics of persistent mycobacterial infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.06.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2008.06.002

1 reference

8 September 2017

1 reference